Question of the Day – Friday December 8, 2017

Question: What should be considered when faced with a neonate suffering withdrawal symptoms purportedly associated with prenatal exposure to either cocaine or methamphetamine?

Answer: The cited reference emphasizes: “Because there is no neonatal abstinence syndrome requiring pharmacologic intervention observed with either prenatal cocaine or methamphetamine exposure, clinicians should investigate for opioid co-exposures when working with a stimulate exposed neonate demonstrating significant withdrawal symptoms. (Smith LM and Santos LS. Prenatal exposure: The effects of prenatal cocaine and methamphetamine exposure on the developing child. 2016 Birth Defects Res. (Part C) 108(2): 142-146)